Sidong Huang

Citado por

	Total	Desde 2019
Citas	6556	3453
Índice h	30	24
Índice i10	37	35

700

350

175

525

1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202418 38 33 28 18 17 19 17 16 14 16 28 55 141 282 359 522 482 450 470 482 563 681 584 563 575

Acceso público

Ver todo

34 artículos

1 artículo

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Rene BernardsNetherlands Cancer InstituteDirección de correo verificada de nki.nl
Roderick BeijersbergenThe Netherlands Cancer InstituteDirección de correo verificada de nki.nl
Chong SunGerman Cancer Research Center (DKFZ)Dirección de correo verificada de dkfz.de
Michael HolzelInstitute of Experimental Oncology, University Hospital Bonn, Germany. Twitter: @IEO_HolzelLabDirección de correo verificada de ukb.uni-bonn.de
Morag ParkProfessor of Oncology and Biochemistry, McGill University, Director Goodman Cancer Research CentreDirección de correo verificada de mcgill.ca
Federica Di NicolantonioUniversity of Torino, Dept of Oncology & Candiolo Cancer Institute, FPO - IRCCSDirección de correo verificada de unito.it
Lodewyk WesselsProfessor of Computational Cancer BiologyDirección de correo verificada de nki.nl
Andreas SchlickerComputational Biology Lead, Bayer AGDirección de correo verificada de bayer.com
Veena SangwanDirección de correo verificada de mcgill.ca
Shahab AsgharzadehAssociate Professor, University of Southern CaliforniaDirección de correo verificada de chla.usc.edu
Jan KosterGroupleader Bioinformatics, AUMC, location AMCDirección de correo verificada de amsterdamumc.nl
Theo KnijnenburgAltius Institute for Biomedical SciencesDirección de correo verificada de altius.org
prashanth kumar BajpePostdoctoral Research ScientistDirección de correo verificada de crick.ac.uk
Marie-Christine GuiotMcGill UniversityDirección de correo verificada de mcgill.ca
Jeremiah M. ScharfCenter for Genomic Medicine, Departments of Neurology & Psychiatry, MGHDirección de correo verificada de broadinstitute.org
William DietrichWhitehead Institute, MIT, Harvard Medical School, NovartisDirección de correo verificada de alum.mit.edu
Jelle WesselingGroup Leader, Netherlands Cancer InstituteDirección de correo verificada de nki.nl
Alexander EGGERMONTPrincess Maxima Center & University Medical Center Utrecht, Netherlands alexander.eggermontDirección de correo verificada de prinsesmaximacentrum.nl
Blank cNetherlands Cancer InstituteDirección de correo verificada de nki.nl
Hamed S. NajafabadiAssociate Professor at McGill UniversityDirección de correo verificada de mcgill.ca

Seguir

Sidong Huang

McGill University

Dirección de correo verificada de mcgill.ca


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Unresponsiveness of colon cancer to BRAF (V600E) inhibition through feedback activation of EGFR A Prahallad, C Sun, S Huang, F Di Nicolantonio, R Salazar, D Zecchin, ... Nature 483 (7387), 100-103, 2012	2245	2012
Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma C Sun, L Wang, S Huang, GJJE Heynen, A Prahallad, C Robert, ... Nature 508 (7494), 118-122, 2014	925	2014
MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling S Huang, M Hölzel, T Knijnenburg, A Schlicker, P Roepman, U McDermott, ... Cell 151 (5), 937-950, 2012	498	2012
Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3 C Sun, S Hobor, A Bertotti, D Zecchin, S Huang, F Galimi, F Cottino, ... Cell reports 7 (1), 86-93, 2014	359	2014
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome M Hölzel, S Huang, J Koster, I Øra, A Lakeman, H Caron, W Nijkamp, ... Cell 142 (2), 218-229, 2010	232	2010
Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics JM Scharf, MG Endrizzi, A Wetter, S Huang, TG Thompson, K Zerres, ... Nature genetics 20 (1), 83-86, 1998	174	1998
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer Y Xue, B Meehan, Z Fu, XQD Wang, PO Fiset, R Rieker, C Levins, T Kong, ... Nature communications 10 (1), 557, 2019	172	2019
ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome S Huang, J Laoukili, MT Epping, J Koster, M Hölzel, BA Westerman, ... Cancer cell 15 (4), 328-340, 2009	157	2009
Phosphorylation of the translation initiation factor eIF2α at serine 51 determines the cell fate decisions of Akt in response to oxidative stress K Rajesh, J Krishnamoorthy, U Kazimierczak, C Tenkerian, AI Papadakis, ... Cell death & disease 6 (1), e1591-e1591, 2015	137	2015
Expression of DRD2 is increased in human pancreatic ductal adenocarcinoma and inhibitors slow tumor growth in mice P Jandaghi, HS Najafabadi, AS Bauer, AI Papadakis, M Fassan, A Hall, ... Gastroenterology 151 (6), 1218-1231, 2016	132	2016
CD44 promotes PD-L1 expression and its tumor-intrinsic function in breast and lung cancers T Kong, R Ahn, K Yang, X Zhu, Z Fu, G Morin, R Bramley, NC Cliffe, Y Xue, ... Cancer research 80 (3), 444-457, 2020	130	2020
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary Y Xue, B Meehan, E Macdonald, S Venneti, XQD Wang, L Witkowski, ... Nature communications 10 (1), 558, 2019	124	2019
Small-cell carcinoma of the ovary, hypercalcemic type–genetics, new treatment targets, and current management guidelines M Tischkowitz, S Huang, S Banerjee, J Hague, WPD Hendricks, ... Clinical Cancer Research 26 (15), 3908-3917, 2020	123	2020
Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway M Drosten, EYM Sum, CG Lechuga, L Simón-Carrasco, HKC Jacob, ... Proceedings of the National Academy of Sciences 111 (42), 15155-15160, 2014	104	2014
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma Y Zhan, J Guo, W Yang, C Goncalves, T Rzymski, A Dreas, E Żyłkiewicz, ... The Journal of clinical investigation 127 (11), 4179-4192, 2017	76	2017
A Systematic High-Throughput Screen of a Yeast Deletion Collection for Mutants Defective in PHO5 Regulation S Huang, EK O'Shea Genetics 169 (4), 1859-1871, 2005	76	2005
SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors T Shorstova, M Marques, J Su, J Johnston, CL Kleinman, N Hamel, ... Cancer research 79 (10), 2761-2774, 2019	70	2019
SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer AI Papadakis, C Sun, TA Knijnenburg, Y Xue, W Grernrum, M Hölzel, ... Cell research 25 (4), 445-458, 2015	70	2015
A general framework for interrogation of mRNA stability programs identifies RNA-binding proteins that govern cancer transcriptomes G Perron, P Jandaghi, S Solanki, M Safisamghabadi, C Storoz, ... Cell Reports 23 (6), 1639-1650, 2018	66	2018
Methods and means for predicting resistance to anti-cancer treatment R Bernards, P Roepman, S Huang US Patent App. 14/434,474, 2015	63	2015

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores